Use of conventional antipsychotics and the cost of treating schizophrenia
- PMID: 12500340
- PMCID: PMC4194719
Use of conventional antipsychotics and the cost of treating schizophrenia
Abstract
This study documents the drug therapy patterns and 1-year treatment costs for 18,833 Medicaid patients with schizophrenia treated with conventional antipsychotic medications in Michigan, Kentucky, Alabama, and Georgia. One in four patients used no antipsychotic, but had total costs that were less than for treated patients (-$2,576, p < .0001); 18 percent of treated patients delayed therapy for at least 1 month and had significantly higher total costs of $3,994 (p < .0001); 41 percent of treated patients changed therapy with similar results (+$4,067, p < .0001). Only 20 percent of patients were compliant with drug therapy but this had no significant impact on total treatment costs.
Figures
References
-
- American Psychiatric Association. Practice Guideline for the Treatment of Patients with Schizophrenia. American Journal of Psychiatry. 1997;154(Suppl. 4) - PubMed
-
- Buckley PF. Treatment of Schizophrenia: Let's Talk Dollars and Sense. American Journal of Managed Care. 1998;4(3):369–383. - PubMed
-
- California's Medical Assistance Program. Annual Statistical Report: Calendar Year 1994. Medical Care Statistics Section, Department of Health Services; Sacramento, CA.: 1995.
-
- California's Medical Assistance Program. Medi-Cal Top 100 Drug Use Report: 1999 Year-to-Date Through June 1999. Medical Care Statistics Section, Department of Health Services; Sacramento, CA.: 1999.
-
- Chassin MR, Brook RH, Park RE, et al. Variations in the Use of Medical and Surgical Services by the Medicare Population. New England Journal of Medicine. 1986;314(5):285–290. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical